COR Quote, Financials, Valuation and Earnings

Cardinal Health has a net margin of 0.95% compared to Cencora's net margin of 0.92%. Cencora's return on equity of 183.42% beat Cardinal Health's return on equity of --.

Cencora has a consensus price target of $324.30, signalling upside risk potential of 8.89%. On the other hand Cardinal Health has an analysts' consensus of $176.41 which suggests that it could grow by 9.5%. Given that Cardinal Health has higher upside potential than Cencora, analysts believe Cardinal Health is more attractive than Cencora.

Cencora has a beta of 0.571, which suggesting that the stock is 42.922% less volatile than S&P 500. In comparison Cardinal Health has a beta of 0.675, suggesting its less volatile than the S&P 500 by 32.48%.

Cencora has a quarterly dividend of $0.55 per share corresponding to a yield of 0.73%. Cardinal Health offers a yield of 1.26% to investors and pays a quarterly dividend of $0.51 per share. Cencora pays 27.58% of its earnings as a dividend. Cardinal Health pays out 58.57% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Cencora quarterly revenues are $75.5B, which are larger than Cardinal Health quarterly revenues of $54.9B. Cencora's net income of $717.9M is higher than Cardinal Health's net income of $506M. Notably, Cencora's price-to-earnings ratio is 34.55x while Cardinal Health's PE ratio is 25.13x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cencora is 0.19x versus 0.18x for Cardinal Health. Usually stocks with elevated PS ratios are considered overvalued.

Integer Holdings has a net margin of 0.95% compared to Cencora's net margin of -5.14%. Cencora's return on equity of 183.42% beat Integer Holdings's return on equity of 4.85%.

Cencora has a consensus price target of $324.30, signalling upside risk potential of 8.89%. On the other hand Integer Holdings has an analysts' consensus of $148.75 which suggests that it could grow by 27%. Given that Integer Holdings has higher upside potential than Cencora, analysts believe Integer Holdings is more attractive than Cencora.

Cencora has a beta of 0.571, which suggesting that the stock is 42.922% less volatile than S&P 500. In comparison Integer Holdings has a beta of 0.980, suggesting its less volatile than the S&P 500 by 1.988%.

Cencora has a quarterly dividend of $0.55 per share corresponding to a yield of 0.73%. Integer Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cencora pays 27.58% of its earnings as a dividend. Integer Holdings pays out -- of its earnings as a dividend. Cencora's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Cencora quarterly revenues are $75.5B, which are larger than Integer Holdings quarterly revenues of $437.4M. Cencora's net income of $717.9M is higher than Integer Holdings's net income of -$22.5M. Notably, Cencora's price-to-earnings ratio is 34.55x while Integer Holdings's PE ratio is 55.51x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cencora is 0.19x versus 2.36x for Integer Holdings. Usually stocks with elevated PS ratios are considered overvalued.

McKesson has a net margin of 0.95% compared to Cencora's net margin of 1.39%. Cencora's return on equity of 183.42% beat McKesson's return on equity of --.

Cencora has a consensus price target of $324.30, signalling upside risk potential of 8.89%. On the other hand McKesson has an analysts' consensus of $767.17 which suggests that it could grow by 7.19%. Given that Cencora has higher upside potential than McKesson, analysts believe Cencora is more attractive than McKesson.

Cencora has a beta of 0.571, which suggesting that the stock is 42.922% less volatile than S&P 500. In comparison McKesson has a beta of 0.482, suggesting its less volatile than the S&P 500 by 51.795%.

Cencora has a quarterly dividend of $0.55 per share corresponding to a yield of 0.73%. McKesson offers a yield of 0.4% to investors and pays a quarterly dividend of $0.71 per share. Cencora pays 27.58% of its earnings as a dividend. McKesson pays out 10.47% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Cencora quarterly revenues are $75.5B, which are smaller than McKesson quarterly revenues of $90.8B. Cencora's net income of $717.9M is lower than McKesson's net income of $1.3B. Notably, Cencora's price-to-earnings ratio is 34.55x while McKesson's PE ratio is 27.71x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cencora is 0.19x versus 0.26x for McKesson. Usually stocks with elevated PS ratios are considered overvalued.

Pineapple has a net margin of 0.95% compared to Cencora's net margin of --. Cencora's return on equity of 183.42% beat Pineapple's return on equity of --.

Cencora has a consensus price target of $324.30, signalling upside risk potential of 8.89%. On the other hand Pineapple has an analysts' consensus of -- which suggests that it could fall by --. Given that Cencora has higher upside potential than Pineapple, analysts believe Cencora is more attractive than Pineapple.

Cencora has a beta of 0.571, which suggesting that the stock is 42.922% less volatile than S&P 500. In comparison Pineapple has a beta of 35.438, suggesting its more volatile than the S&P 500 by 3443.784%.

Cencora has a quarterly dividend of $0.55 per share corresponding to a yield of 0.73%. Pineapple offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cencora pays 27.58% of its earnings as a dividend. Pineapple pays out -- of its earnings as a dividend. Cencora's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Cencora quarterly revenues are $75.5B, which are larger than Pineapple quarterly revenues of --. Cencora's net income of $717.9M is higher than Pineapple's net income of --. Notably, Cencora's price-to-earnings ratio is 34.55x while Pineapple's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cencora is 0.19x versus 81.14x for Pineapple. Usually stocks with elevated PS ratios are considered overvalued.